NCT03323554 - Safety and Efficacy Study of USTRAP™ in Male Urinary Incontinence | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2026

Conditions

Urinary Incontinence

Interventions

DEVICE

Ustrap®

Patients will receive Ustrap® under general or loco-regional anaesthesia, by perineal approach.

DEVICE

AMS 800®

Patients will receive AMS 800® under general or loco-regional anaesthesia. Small openings are made near the scrotum and below the abdomen to insert an inflatable cuff, a pump and a small balloon (pressure regulating balloon).

Trial Locations (1)

76031

CHU Charles Nicolle, Rouen